We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$55B
AUM Growth
+$9.39B
(+21%)
Cap. Flow
+$2.93B
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,453
New
57
Increased
842
Reduced
455
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$721M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$188M |
| 3 |
RTX Corp
RTX
|
+$182M |
| 4 |
Keysight
KEYS
|
+$166M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$328M |
| 2 |
Guidewire Software
GWRE
|
+$193M |
| 3 |
Tradeweb Markets
TW
|
+$188M |
| 4 |
Domino's
DPZ
|
+$168M |
| 5 |
Amgen
AMGN
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 30.72% |
| 2 | Technology | 30.7% |
| 3 | Healthcare | 8.19% |
| 4 | Financials | 8.05% |
| 5 | Energy | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Globant
GLOB
$1.58B
| $39K | ﹤0.01% |
162
+17
| +12% | +$3.47K |
|
1302
NeoGenomics
NEO
$1.96B
| $38K | ﹤0.01% |
2,374
+402
| +20% | +$6.58K |
|
1303
Novanta
NOVT
$5.08B
| $38K | ﹤0.01% |
226
+41
| +22% | +$5.98K |
|
|
AZPN
1304
DELISTED
Aspen Technology Inc
AZPN
| $37K | ﹤0.01% |
169
-13
| -7% | -$2.5K |
|
1305
Federated Hermes
FHI
$4.55B
| $36K | ﹤0.01% |
1,052
-18,411
| -95% | -$600K |
|
1306
Omnicell
OMCL
$1.61B
| $36K | ﹤0.01% |
944
+156
| +20% | +$5.74K |
|
1307
Vitamin Cottage Natural Grocers
NGVC
$739M
| $34K | ﹤0.01% |
2,154
-236
| -10% | -$3.43K |
|
1308
ATS Corp
ATS
$2.64B
| $33K | ﹤0.01% |
764
+271
| +55% | +$10.5K |
|
1309
Brookfield Renewable
BEP
$9.97B
| $32K | ﹤0.01% |
1,200
| – | – |
|
1310
Beam Therapeutics
BEAM
$2.63B
| $31K | ﹤0.01% |
1,145
+57
| +5% | +$1.42K |
|
|
CRESY
1311
Cresud
CRESY
$795M
| $31K | ﹤0.01% |
3,339
-198
| -6% | -$1.62K |
|
1312
Seneca Foods Class A
SENEA
$1.12B
| $31K | ﹤0.01% |
596
-65
| -10% | -$3.4K |
|
|
FPI
1313
Farmland Partners
FPI
$408M
| $30K | ﹤0.01% |
2,428
-164
| -6% | -$1.9K |
|
1314
VanEck High Yield Muni ETF
HYD
$4.43B
| $30K | ﹤0.01% |
580
+10
| +2% | +$495 |
|
1315
VanEck Intermediate Muni ETF
ITM
$2.14B
| $30K | ﹤0.01% |
645
+5
| +0.8% | +$225 |
|
1316
VanEck Mortgage REIT Income ETF
MORT
$376M
| $30K | ﹤0.01% |
2,556
| – | – |
|
|
HOLI
1317
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $29K | ﹤0.01% |
1,106
+325
| +42% | +$7.3K |
|
|
ALTR
1318
DELISTED
Altair Engineering Inc
ALTR
| $28K | ﹤0.01% |
331
+49
| +17% | +$3.41K |
|
1319
Cohen & Steers
CNS
$4.23B
| $27K | ﹤0.01% |
357
-124
| -26% | -$7.46K |
|
1320
Symbotic
SYM
$5.48B
| $26K | ﹤0.01% |
+503
| New | +$22.1K |
|
1321
Lattice Semiconductor
LSCC
$17.6B
| $25K | ﹤0.01% |
357
+174
| +95% | +$11.6K |
|
1322
LSB Industries
LXU
$783M
| $25K | ﹤0.01% |
2,731
+74
| +3% | +$675 |
|
1323
Phreesia
PHR
$663M
| $25K | ﹤0.01% |
1,096
+317
| +41% | +$5.47K |
|
1324
Ambarella
AMBA
$3.77B
| $24K | ﹤0.01% |
395
+100
| +34% | +$5.46K |
|
1325
Mission Produce
AVO
$1.11B
| $24K | ﹤0.01% |
2,389
-87
| -4% | -$808 |
|
Similar funds
VanEck Associates's Q4 2023 Portfolio in Review
As of Q4 2023, VanEck Associates held 1,453 positions worth $55B, up 21% from $45.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates deployed $2.93B of net new capital in Q4 2023, opening 57 new positions and adding to 842 existing holdings. Its largest new stake was Caterpillar: 75,101 shares worth $22.2M.
By sector, the portfolio is most concentrated in Materials at 31% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $328M trimmed.
- VanEck Associates's largest Q4 2023 buy was Caterpillar: 75,101 shares worth $22.2M.
- VanEck Associates added most to Newmont in Q4 2023, an estimated $721M increase.
- VanEck Associates's biggest Q4 2023 reduction was TSMC, cutting an estimated $328M.
- VanEck Associates fully exited Lithium Americas Corp. Common Shares in Q4 2023, selling an estimated $28.3M.
- VanEck Associates's ten largest holdings make up 24% of its $55B portfolio in Q4 2023.
- VanEck Associates opened 57 new positions and closed 60 in Q4 2023.
- VanEck Associates's portfolio value rose 21% quarter-over-quarter to $55B.
Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.